Contrast Sensitivity and Color Vision Comparison Between Clear and Yellow-Tinted Intraocular Lens in Diabetic Retinopathy

2012 ◽  
Vol 53 (2) ◽  
pp. 238 ◽  
Author(s):  
Kyung O Lim ◽  
Tai Jin Kim ◽  
Joo Hwa Lee
Keyword(s):  
Diabetic Retinopathy ◽  
Contrast Sensitivity ◽  
Color Vision ◽  
Intraocular Lens

scholarly journals Visual Function Tests as cost Effective Screening Tools For Diabetic Retinopathy

2020 ◽  
Vol 36 (1) ◽  
Author(s):  
Faryal Ahmed ◽  
Faraz Iftikhar Malik ◽  
Chaudhary Ehtsham Azmat ◽  
Ambreen Gul ◽  
Ali Raza
Keyword(s):  
Visual Acuity ◽  
Diabetic Retinopathy ◽  
Contrast Sensitivity ◽  
Color Vision ◽  
Visual Function ◽  
Cost Effective ◽  
Screening Tools ◽  
Diabetic Patients ◽  
Effective Screening ◽  
Function Tests

Purpose:  To find out the importance of visual function tests as cost effective screening tools for diabetic retinopathy. Study Design:  Descriptive, Cross sectional study. Place and Duration of Study:  Ophthalmology Unit of Holy Family Hospital, from September 2018 to November 2018. Material and Methods:  Two hundred and forty-two patients were selected by convenience sampling technique and were divided into three groups. Two groups of diabetics with and without retinopathy and one group of non-diabetics age-matched controls. After relevant history, patients were examined for Visual acuity, Color vision and Contrast sensitivity using Snellen’s Chart, 24 Plates Ishihara Chart and Pelli Robson Chart respectively. Staging of retinopathy was done after mydriasis. Results:  Diabetic patients irrespective of type and stage, when compared with non-diabetic patients had a greater percentage of abnormal visual function tests. A 6/6 visual acuity was observed in 38.2% of non diabetics as compared to only 8.6% diabetics without retinopathy and 7.5% of diabetics with retinopathy. Color vision abnormalities were detected in only 8.6% of non diabetic patients. However, 11.1% of diabetics without retinopathy and 23.7% with retinopathy showed abnormalities of color vision. The percentage of abnormal Contrast sensitivity was 76.2% for diabetics with retinopathy and 60.4% for diabetics without retinopathy and 27.1% for non-diabetic patients. Conclusion:  Evaluation of Visual Acuity, Color Vision and Contrast Sensitivity are cheap and easy tests that can be used to screen for diabetic retinopathy thereby allowing early interventions to prevent development of serious ocular diabetic complications.

scholarly journals Objective and subjective evaluation of trifocal diffractive intraocular Lens after cataract extraction with phacoemulsification: a prospective clinical study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ahmed A. Zein El-Dein ◽  
Ahmed Elmassry ◽  
Hazem M. El-Hennawi ◽  
Ehab F. Mossallam
Keyword(s):  
Visual Acuity ◽  
Contrast Sensitivity ◽  
Intraocular Lens ◽  
Subjective Evaluation ◽  
Cataract Extraction ◽  
Prospective Clinical Study ◽  
Gradual Change ◽  
Quality Of Vision ◽  
Defocus Curve

Abstract Background This study aimed to assess visual outcomes, quality of vision and patients’ satisfaction of a trifocal diffractive intraocular lens after cataract surgery with phacoemulsification. Results The study included 36 eyes that underwent implantation of trifocal diffractive intraocular lens (IOL). The residual mean postoperative spherical equivalent was − 0.40 ± 0.29 diopters. Mean Uncorrected distance visual acuity was 0.80 ± 0.16 decimal (snellen equivalent 25 ft) while mean Uncorrected intermediate visual acuity was 0.82 ± 0.31 decimal (snellen equivalent 25 ft) and mean Uncorrected near visual acuity (UCNVA) was 0.87 ± 0.20 decimal (snellen equivalent 23 ft). In defocus curve, there was infinitesimal gradual change between the three foci. Contrast sensitivity was just below the inferior limit of normal. Conclusion Trifocal diffractive IOL created a true intermediate focus proved by VA and defocus curve and better quality of vision assessed by contrast sensitivity and high order aberration. Moreover, it was safe and effective for correcting distance and near vision in these patients. Most of the patients were very satisfied and achieved spectacle independence. Trial registration Registration number and date: NCT04465279 on July 10, 2020.

Effect of blue light-filtering intraocular lens on color vision in patients with macular diseases after vitrectomy

2016 ◽  
Vol 36 (6) ◽  
pp. 829-839
Author(s):  
Kumiko Mokuno ◽  
Tetsu Asami ◽  
Norie Nonobe ◽  
Hirotaka Ito ◽  
Kumi Fujiwara ◽  
...  
Keyword(s):  
Color Vision ◽  
Blue Light ◽  
Intraocular Lens ◽  
Macular Diseases

Wavefront Analysis, Contrast Sensitivity, and Depth of Focus After Cataract Surgery With Aspherical Intraocular Lens Implantation

2010 ◽  
Vol 149 (3) ◽  
pp. 383-389.e2 ◽  
Author(s):  
Marcony R. Santhiago ◽  
Marcelo V. Netto ◽  
Jackson Barreto ◽  
Beatriz A.F. Gomes ◽  
Adriana Mukai ◽  
...  
Keyword(s):  
Cataract Surgery ◽  
Contrast Sensitivity ◽  
Intraocular Lens ◽  
Intraocular Lens Implantation ◽  
Depth Of Focus ◽  
Wavefront Analysis ◽  
Lens Implantation

scholarly journals Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma

2015 ◽  
Vol 9 (1) ◽  
pp. 131-135 ◽  
Author(s):  
Irena Tsui ◽  
Robert M Beardsley ◽  
Tara A McCannel ◽  
Scott C Oliver ◽  
Melissa W Chun ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Contrast Sensitivity ◽  
Color Vision ◽  
Ciliary Body ◽  
Case Series ◽  
Vision Measurement ◽  
Corrected Visual Acuity ◽  
Iodine 125 ◽  
Decrease In Visual Acuity ◽  
Ciliary Body Melanoma

Purpose : To report visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after iodine-125 brachytherapy for choroidal and ciliary body melanoma (CCM). Design : Prospective interventional case series. Participants : Thirty-seven patients (37 eyes) with CCM. Methods : Patients had best-corrected Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, Pelli-Robson contrast sensitivity and Hardy-Rand-Rittler color vision measurement; comprehensive ophthalmology examination; optical coherence tomography; and ultrasonography at baseline prior to, 1 year after, 2 years after and 3 years after I-125 brachytherapy. Main Outcome Measures : Visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after brachytherapy. Results : Nineteen (19) men and 18 women with mean age of 58 years (SD 13, range 30-78) prior to, 1 year after, 2 years after and 3 years after brachytherapy had mean best-corrected visual acuity of 77 letters (20/32), 65 letters (20/50), 56 letters (20/80) and 47 letters (20/125); contrast sensitivity of 30, 26, 22 and 19 letters; color vision of 26, 20, 17 and 14 test figures, respectively. Decrease in visual acuity, contrast sensitivity and color vision was statistically significant from baseline at 1 year, 2 years, and 3 years after brachytherapy. Decreased acuity at 3 years was associated with mid-choroid and macula melanoma location, ≥ 4.1 mm melanoma height, radiation maculopathy and radiation optic neuropathy. Conclusion : 1, 2 and 3 years after brachytherapy, eyes with CCM had significantly decreased visual acuity, contrast sensitivity and color vision.

Prediction of Diabetic Retinopathy from Clinical Variables and Color Vision Data

Diabetes Care ◽  
1983 ◽  
Vol 6 (2) ◽  
pp. 144-148 ◽  
Author(s):  
P. A. Aspinall ◽  
P. R. Kinnear ◽  
L. J. P. Duncan ◽  
B. F. Clarke
Keyword(s):  
Diabetic Retinopathy ◽  
Color Vision ◽  
Clinical Variables

scholarly journals Clinical outcomes with a diffractive trifocal intraocular lens

2018 ◽  
Vol 28 (4) ◽  
pp. 419-424 ◽  
Author(s):  
Jorge L Alió ◽  
Ana B Plaza-Puche ◽  
Jorge L Alió del Barrio ◽  
Pedro Amat-Peral ◽  
Vicente Ortuño ◽  
...  
Keyword(s):  
Visual Acuity ◽  
Contrast Sensitivity ◽  
Intraocular Lens ◽  
Case Series ◽  
Optical Quality ◽  
Near Vision ◽  
Case Series Study ◽  
Defocus Curve ◽  
Near Visual Acuity

Purpose: To evaluate clinical and visual outcomes, quality of near vision, and intraocular optical quality of patients bilaterally implanted with a trifocal PanOptix intraocular lens. Methods: In this prospective consecutive case-series study, 52 eyes of 26 bilateral patients (mean age, 60.2 ± 7.4 years) were implanted with the AcrySof IQ Panoptix intraocular lens. Visual acuity, defocus curve, contrast sensitivity (Pelli-Robson test), near activity visual questionnaire, and internal aberrations with Osiris were evaluated. A prototype light-distortion analyzer was used to quantify the postoperative light-distortion indices. The follow-up was 6 months after surgery. Results: Uncorrected, corrected distance, and uncorrected near visual acuities improved with the surgery (p ≤ 0.02). Distance corrected near visual acuity was 0.13 ± 0.10, 0.13 ± 0.13, and 0.13 ± 0.08 at 1, 3, and 6 months after surgery, respectively (p = 0.82). Distance corrected intermediate visual acuities were 0.09 ± 0.13, 0.13 ± 0.15, and 0.12 ± 0.12 at 1, 3, and 6 months, postoperatively. Binocular contrast sensitivity was 1.86 ± 0.15 Log Units. Defocus curve provided a visual acuity equal or better to 0.30 LogMAR between defocus levels of +0.50 to −3.00 D. The near activity visual questionnaire scores improved significantly with the surgery (p < 0.01). Conclusion: The AcrySof IQ Panoptix intraocular lens is able to restore visual function with an acceptable intermediate and near vision after cataract surgery with good contrast sensitivity and an improvement in the near activity visual questionnaire.

Sign in / Sign up

Export Citation Format

Share Document